세계의 다낭성 난소증후군(PCOS) 치료 시장 예측, 경쟁 동향, 성장 기회(-2025년) : 수술 구분, 약제, 진단법, 최종사용자, 지역별

Global PCOS Treatment Market, By Surgery, By Drug, By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025

US $ 4,450 ￦ 4,935,000

Unprintable PDF and Excel (Single User License)

US $ 5,450 ￦ 6,044,000

PDF and Excel (Multi-User License)

US $ 9,450 ￦ 10,480,000

PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.

한글목차

세계의 다낭성 난소증후군(PCOS) 치료 시장 규모는 2019년 약 33억 9000만 달러에서 예측기간 중 약 8.63%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측됩니다. 여성의 당뇨병 및 비만 증가, 여성 호르몬 균형 파괴, 신약 및 새로운 치료 옵션 개발 등의 요인이 시장 성장을 가속할 전망입니다.

세계의 다낭성 난소증후군(PCOS) 치료 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 세계 및 지역/국가별 시장 규모 및 시장 점유율 추이와 예측, 수술 구분·약제·진단법·최종사용자 등 각종 구분별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리했습니다.

제1장 제품 개요

제2장 조사 방법

제3장 COVID-19의 영향

제4장 고객의 견해

제5장 개요

제6장 세계 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
  • 난소 설상 절제술
  • 낭포 흡인
  • 복강경하 난소 천공
• 약제별
  • 배란 유도제
  • 인슐린 감작제
  • 경구 피임약
  • 항안드로겐
  • 항우울제
  • 인슐린 감작제
  • 항비만제
  • 기타
• 진단별
  • 골반검사
  • 초음파
  • 혈액검사
• 최종사용자별
  • 병원/클리닉
  • 외래수술센터
  • 불임 치료 클리닉
• 기업별
• 지역별
• 제품 시장 맵

제7장 아시아태평양 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
• 약제별
• 진단별
• 최종사용자별
• 국가별
• 국가별 분석

제8장 유럽 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
• 약제별
• 진단별
• 최종사용자별
• 국가별
• 국가별 분석

제9장 북미 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
• 약제별
• 진단별
• 최종사용자별
• 국가별
• 국가별 분석

제10장 남미 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
• 약제별
• 진단별
• 최종사용자별
• 국가별
• 국가별 분석

제11장 중동 및 아프리카 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 수술별
• 약제별
• 진단별
• 최종사용자별
• 국가별
• 국가별 분석

제12장 시장 역학

• 촉진요인
• 과제

제13장 시장 동향

제14장 각종 증상을 위한 일반적인 다낭성 난소증후군(PCOS) 의약품

제15장 경쟁 구도

• Bristol-Myers Squibb Company
• Bayer AG
• Pfizer, Inc.
• Abbott Laboratories, Inc.
• Merck & Co., Inc.
• Sanofi SA
• AstraZeneca Plc
• Novartis AG
• Teva Pharmaceutical Industries Limited
• Ferring Pharmaceuticals, Inc.

제16장 전략적 제안

제17장 당사에 대해/면책사항

LSH 21.01.11

영문 목차

영문목차

Title:
Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025.

Global PCOS treatment market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of market through 2025.

The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the global PCOS treatment market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to dominate the global PCOS treatment market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

• To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.

• To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.

• To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.

• To identify dominant region or segment in the global PCOS treatment market.

• To identify drivers and challenges for global PCOS treatment market.

• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.

• To identify and analyze the profile of leading players operating in global PCOS treatment market.

• To identify key sustainable strategies adopted by market players in global PCOS treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global PCOS treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders

• Government bodies such as regulating authorities and policy makers

• Organizations, forums and alliances related to PCOS treatment

• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global PCOS treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global PCOS Treatment Market, By Surgery:
• Laparoscopic Ovarian Drilling
• Cyst Aspiration
• Ovarian Wedge Resection
• Global PCOS Treatment Market, By Drug:
• Ovulation Inducing Agents
• Insulin-Sensitizing Agents
• Oral Contraceptives
• Antiandrogens
• Anti-Obesity Drugs
• Anti-Depressants
• Others
• Global PCOS Treatment Market, By Diagnosis:

Pelvic Examination

Ultrasound

Blood Tests

• Global PCOS Treatment Market, By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Fertility Clinics

• Global PCOS Treatment Market, By Region:

North America

• United States
• Canada
• Mexico

Europe

• Germany
• France
• United Kingdom
• Italy
• Spain

Asia-Pacific

• China
• Japan
• India
• South Korea
• Australia

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE

South America

• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global PCOS treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global PCOS Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)
  • 6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
  • 6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
  • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
  • 6.2.5. By Company (2019)
  • 6.2.6. By Region
• 6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Surgery
  • 7.2.2. By Drug
  • 7.2.3. By Diagnosis
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Asia-Pacific: Country Analysis
  • 7.3.1. China PCOS Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Surgery
      • 7.3.1.2.2. By Drug
      • 7.3.1.2.3. By Diagnosis
      • 7.3.1.2.4. By End User
  • 7.3.2. India PCOS Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Surgery
      • 7.3.2.2.2. By Drug
      • 7.3.2.2.3. By Diagnosis
      • 7.3.2.2.4. By End User
  • 7.3.3. Australia PCOS Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Surgery
      • 7.3.3.2.2. By Drug
      • 7.3.3.2.3. By Diagnosis
      • 7.3.3.2.4. By End User
  • 7.3.4. Japan PCOS Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Surgery
      • 7.3.4.2.2. By Drug
      • 7.3.4.2.3. By Diagnosis
      • 7.3.4.2.4. By End User
  • 7.3.5. South Korea PCOS Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Surgery
      • 7.3.5.2.2. By Drug
      • 7.3.5.2.3. By Diagnosis
      • 7.3.5.2.4. By End User

8. Europe PCOS Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Surgery
  • 8.2.2. By Drug
  • 8.2.3. By Diagnosis
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France PCOS Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Surgery
      • 8.3.1.2.2. By Drug
      • 8.3.1.2.3. By Diagnosis
      • 8.3.1.2.4. By End User
  • 8.3.2. Germany PCOS Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Surgery
      • 8.3.2.2.2. By Drug
      • 8.3.2.2.3. By Diagnosis
      • 8.3.2.2.4. By End User
  • 8.3.3. United Kingdom PCOS Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Surgery
      • 8.3.3.2.2. By Drug
      • 8.3.3.2.3. By Diagnosis
      • 8.3.3.2.4. By End User
  • 8.3.4. Italy PCOS Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Surgery
      • 8.3.4.2.2. By Drug
      • 8.3.4.2.3. By Diagnosis
      • 8.3.4.2.4. By End User
  • 8.3.5. Spain PCOS Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Surgery
      • 8.3.5.2.2. By Drug
      • 8.3.5.2.3. By Diagnosis
      • 8.3.5.2.4. By End User

9. North America PCOS Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Surgery
  • 9.2.2. By Drug
  • 9.2.3. By Diagnosis
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States PCOS Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Surgery
      • 9.3.1.2.2. By Drug
      • 9.3.1.2.3. By Diagnosis
      • 9.3.1.2.4. By End User
  • 9.3.2. Mexico PCOS Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Surgery
      • 9.3.2.2.2. By Drug
      • 9.3.2.2.3. By Diagnosis
      • 9.3.2.2.4. By End User
  • 9.3.3. Canada PCOS Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Surgery
      • 9.3.3.2.2. By Drug
      • 9.3.3.2.3. By Diagnosis
      • 9.3.3.2.4. By End User

10. South America PCOS Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Surgery
  • 10.2.2. By Drug
  • 10.2.3. By Diagnosis
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil PCOS Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Surgery
      • 10.3.1.2.2. By Drug
      • 10.3.1.2.3. By Diagnosis
      • 10.3.1.2.4. By End User
  • 10.3.2. Argentina PCOS Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Surgery
      • 10.3.2.2.2. By Drug
      • 10.3.2.2.3. By Diagnosis
      • 10.3.2.2.4. By End User
  • 10.3.3. Colombia PCOS Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Surgery
      • 10.3.3.2.2. By Drug
      • 10.3.3.2.3. By Diagnosis
      • 10.3.3.2.4. By End User

11. Middle East and Africa PCOS Treatment Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Surgery
  • 11.2.2. By Drug
  • 11.2.3. By Diagnosis
  • 11.2.4. By End User
  • 11.2.5. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa PCOS Treatment Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Surgery
      • 11.3.1.2.2. By Drug
      • 11.3.1.2.3. By Diagnosis
      • 11.3.1.2.4. By End User
  • 11.3.2. Saudi Arabia PCOS Treatment Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Surgery
      • 11.3.2.2.2. By Drug
      • 11.3.2.2.3. By Diagnosis
      • 11.3.2.2.4. By End User
  • 11.3.3. UAE PCOS Treatment Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Surgery
      • 11.3.3.2.2. By Drug
      • 11.3.3.2.3. By Diagnosis
      • 11.3.3.2.4. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Commonly Used PCOS Drugs to control different symptoms

15. Competitive Landscape

• 15.1. Bristol-Myers Squibb Company
• 15.2. Bayer AG
• 15.3. Pfizer, Inc.
• 15.4. Abbott Laboratories, Inc.
• 15.5. Merck & Co., Inc.
• 15.6. Sanofi SA
• 15.7. AstraZeneca Plc
• 15.8. Novartis AG
• 15.9. Teva Pharmaceutical Industries Limited
• 15.10. Ferring Pharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer